Joanne E. Schottinger

5.2k total citations · 2 hit papers
74 papers, 3.5k citations indexed

About

Joanne E. Schottinger is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Joanne E. Schottinger has authored 74 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 35 papers in Pulmonary and Respiratory Medicine and 11 papers in Surgery. Recurrent topics in Joanne E. Schottinger's work include Colorectal Cancer Screening and Detection (42 papers), Gastric Cancer Management and Outcomes (29 papers) and Global Cancer Incidence and Screening (12 papers). Joanne E. Schottinger is often cited by papers focused on Colorectal Cancer Screening and Detection (42 papers), Gastric Cancer Management and Outcomes (29 papers) and Global Cancer Incidence and Screening (12 papers). Joanne E. Schottinger collaborates with scholars based in United States, Switzerland and Netherlands. Joanne E. Schottinger's co-authors include Douglas A. Corley, Theodore R. Levin, Christopher D. Jensen, Chyke A. Doubeni, Virginia P. Quinn, Ann G. Zauber, Wei Zhao, Jeffrey K. Lee, Nirupa R. Ghai and Charles P. Quesenberry and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Joanne E. Schottinger

72 papers receiving 3.5k citations

Hit Papers

Adenoma Detection Rate and Risk of Colorectal Cancer and ... 2014 2026 2018 2022 2014 2018 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanne E. Schottinger United States 25 3.0k 2.1k 879 678 277 74 3.5k
Joanna Didkowska Poland 16 2.3k 0.8× 1.8k 0.9× 694 0.8× 446 0.7× 241 0.9× 77 2.9k
Urszula Wojciechowska Poland 12 2.2k 0.7× 1.8k 0.8× 677 0.8× 436 0.6× 235 0.8× 54 2.7k
Ewa Kraszewska Poland 19 2.7k 0.9× 2.3k 1.1× 930 1.1× 752 1.1× 214 0.8× 56 3.3k
Øyvind Holme Norway 20 2.0k 0.7× 1.4k 0.7× 664 0.8× 550 0.8× 138 0.5× 71 2.5k
Heiko Pohl United States 29 2.6k 0.9× 3.4k 1.6× 2.9k 3.3× 412 0.6× 283 1.0× 161 5.1k
Seth N. Glick United States 9 2.8k 0.9× 1.7k 0.8× 775 0.9× 970 1.4× 329 1.2× 19 3.2k
Beth G. McFarland United States 4 2.2k 0.7× 1.3k 0.6× 525 0.6× 849 1.3× 186 0.7× 4 2.5k
Maciej Rupiński Poland 18 3.1k 1.0× 2.6k 1.2× 1.0k 1.2× 822 1.2× 221 0.8× 42 3.4k
Paul C. Schroy United States 32 2.5k 0.8× 1.3k 0.6× 713 0.8× 971 1.4× 195 0.7× 91 3.5k
Leon M.G. Moons Netherlands 27 1.6k 0.5× 1.6k 0.8× 1.3k 1.4× 183 0.3× 143 0.5× 112 2.7k

Countries citing papers authored by Joanne E. Schottinger

Since Specialization
Citations

This map shows the geographic impact of Joanne E. Schottinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanne E. Schottinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanne E. Schottinger more than expected).

Fields of papers citing papers by Joanne E. Schottinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanne E. Schottinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanne E. Schottinger. The network helps show where Joanne E. Schottinger may publish in the future.

Co-authorship network of co-authors of Joanne E. Schottinger

This figure shows the co-authorship network connecting the top 25 collaborators of Joanne E. Schottinger. A scholar is included among the top collaborators of Joanne E. Schottinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanne E. Schottinger. Joanne E. Schottinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Podmore, Clara, Kevin Selby, Christopher D. Jensen, et al.. (2024). Colorectal Cancer Screening After Sequential Outreach Components in a Demographically Diverse Cohort. JAMA Network Open. 7(4). e245295–e245295. 2 indexed citations
2.
Levin, Theodore R., Christopher D. Jensen, Natalia Udaltsova, et al.. (2024). 1087 FECAL IMMUNOCHEMICAL TEST UPTAKE AND YIELD IN PATIENTS AGES 45-49 VERSUS 50 YEARS IN THE FIRST YEAR AFTER LOWERING THE AGE OF COLORECTAL CANCER SCREENING INITIATION. Gastroenterology. 166(5). S–259. 1 indexed citations
3.
Lee, Jeffrey K., Christopher D. Jensen, Natalia Udaltsova, et al.. (2024). Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large Community-Based Setting. The American Journal of Gastroenterology. 119(8). 1590–1599. 3 indexed citations
4.
Levin, Theodore R., Christopher D. Jensen, Natalia Udaltsova, et al.. (2024). Colorectal Cancer Screening Completion and Yield in Patients Aged 45 to 50 Years. Annals of Internal Medicine. 177(12). 1621–1629. 3 indexed citations
5.
Chubak, Jessica, Laura Ichikawa, Rebecca A. Ziebell, et al.. (2024). Incidence of Serious Complications following Screening Colonoscopy in Adults Ages 76 to 85 Years. Cancer Epidemiology Biomarkers & Prevention. 34(2). 281–289.
6.
Lee, Jeffrey K., Abhik Roy, Christopher D. Jensen, et al.. (2024). Surveillance Colonoscopy Findings in Older Adults With a History of Colorectal Adenomas. JAMA Network Open. 7(4). e244611–e244611. 3 indexed citations
7.
Ziebell, Rebecca A., Aruna Kamineni, Amanda I. Phipps, et al.. (2023). Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning One Year after a Negative Fecal Occult Blood Test, among Screen-Eligible 76- to 85-Year-Olds. Cancer Epidemiology Biomarkers & Prevention. 32(10). 1382–1390. 1 indexed citations
8.
Corley, Douglas A., Christopher D. Jensen, Jessica Chubak, et al.. (2023). Evaluating Different Approaches for Calculating Adenoma Detection Rate: Is Screening Colonoscopy the Gold Standard?. Gastroenterology. 165(3). 784–787.e4. 6 indexed citations
9.
Ziebell, Rebecca A., Aruna Kamineni, Amanda I. Phipps, et al.. (2022). Risk of Colorectal Cancer and Colorectal Cancer Mortality Beginning Ten Years after a Negative Colonoscopy, among Screen-Eligible Adults 76 to 85 Years Old. Cancer Epidemiology Biomarkers & Prevention. 32(1). 37–45. 6 indexed citations
10.
Ghai, Nirupa R., Christopher D. Jensen, Joanne E. Schottinger, et al.. (2020). Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems. Cancer Prevention Research. 13(11). 947–958. 6 indexed citations
11.
Corley, Douglas A., Debra P. Ritzwoller, Robert T. Greenlee, et al.. (2020). Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute’s PROSPR Consortium. Gastroenterology. 160(4). 999–1002. 37 indexed citations
12.
Lee, Jeffrey K., Christopher D. Jensen, Theodore R. Levin, et al.. (2019). Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. Gastroenterology. 158(4). 884–894.e5. 93 indexed citations
13.
Jensen, Christopher D., Amy R. Marks, Wei Zhao, et al.. (2018). Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointestinal Endoscopy. 89(1). 168–176.e3. 32 indexed citations
14.
Levin, Theodore R., Douglas A. Corley, Christopher D. Jensen, et al.. (2018). Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 155(5). 1383–1391.e5. 339 indexed citations breakdown →
15.
Doubeni, Chyke A., Stacey A. Fedewa, Theodore R. Levin, et al.. (2018). Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology. 156(1). 63–74.e6. 80 indexed citations
16.
Kanter, Michael H., et al.. (2017). A Model for Implementing Evidence-Based Practices More Quickly. 7 indexed citations
17.
Spence, Michele M., Rita L. Hui, Jennifer Chang, et al.. (2017). Treatment Patterns and Overall Survival Associated with First-Line Systemic Therapy for Patients with Advanced Non-Small Cell Lung Cancer. Journal of Managed Care & Specialty Pharmacy. 23(2). 195–205. 13 indexed citations
18.
Chubak, Jessica, Michael P. Garcia, Andrea N. Burnett‐Hartman, et al.. (2016). Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiology Biomarkers & Prevention. 25(2). 344–350. 100 indexed citations
19.
Balogh, Erin P., Peter B. Bach, Peter D. Eisenberg, et al.. (2013). Practice-Changing Strategies to Deliver Affordable, High-Quality Cancer Care: Summary of an Institute of Medicine Workshop. Journal of Oncology Practice. 9(6S). 54s–59s. 6 indexed citations
20.
Haque, Reina, et al.. (2010). Aromatase inhibitor and tamoxifen's impact on breast cancer recurrence among survivors in a large HMO.. Journal of Clinical Oncology. 28(15_suppl). 626–626. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026